According to Minnow Medical, the catheter utilizes the company’s Guided Reshaping Technology (GRT) to treat peripheral artery disease (PAD).
Minnow said that its GRT treats artery disease by precise delivery of controlled radio frequency (RF) energy to open diseased arteries. The RF energy is delivered through electrodes on the surface of a specially designed disposable angioplasty balloon catheter.
Minnow is currently conducting clinical trials in Europe with a first-generation version of its catheter system.
Tom Steinke, president and CEO of Minnow Medical, said: “We are very pleased to receive the CE Mark, and look forward to continuing to educate the European market about the advantages of our technology to treat PAD. Our catheter system is easy to use, and involves a shorter, less complex procedure compared with angioplasty, atherectomy or laser treatments.”